{"title":"戒烟药物:牙科专业人员摘要。","authors":"David I Tindle","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Currently, seven pharmaceutical products are approved by the United States Food and Drug Administration for smoking cessation. Five of these are nicotine replacement products. The remaining two are the non-nicotine containing medications varenicline and bupropion. This paper provides a summary of these smoking cessation pharmaceuticals for dental health professionals.</p>","PeriodicalId":76676,"journal":{"name":"The Journal of the Michigan Dental Association","volume":"99 5","pages":"34-8, 102"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Smoking Cessation Drugs: A Summary for Dental Professionals.\",\"authors\":\"David I Tindle\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Currently, seven pharmaceutical products are approved by the United States Food and Drug Administration for smoking cessation. Five of these are nicotine replacement products. The remaining two are the non-nicotine containing medications varenicline and bupropion. This paper provides a summary of these smoking cessation pharmaceuticals for dental health professionals.</p>\",\"PeriodicalId\":76676,\"journal\":{\"name\":\"The Journal of the Michigan Dental Association\",\"volume\":\"99 5\",\"pages\":\"34-8, 102\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Michigan Dental Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Michigan Dental Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Smoking Cessation Drugs: A Summary for Dental Professionals.
Currently, seven pharmaceutical products are approved by the United States Food and Drug Administration for smoking cessation. Five of these are nicotine replacement products. The remaining two are the non-nicotine containing medications varenicline and bupropion. This paper provides a summary of these smoking cessation pharmaceuticals for dental health professionals.